Polar Asset Management Partners Inc. acquired a new stake in shares of Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 800,000 shares of the company’s stock, valued at approximately $14,752,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Millennium Management LLC acquired a new stake in Translational Development Acquisition in the 4th quarter valued at $7,376,000. Moore Capital Management LP acquired a new stake in Translational Development Acquisition in the 4th quarter valued at $1,844,000. Linden Advisors LP acquired a new stake in Translational Development Acquisition in the 4th quarter valued at $11,064,000. LMR Partners LLP acquired a new stake in Translational Development Acquisition in the 4th quarter valued at $14,752,000. Finally, K2 Principal Fund L.P. acquired a new stake in Translational Development Acquisition in the 4th quarter valued at $12,447,000.
Translational Development Acquisition Trading Up 0.4%
Shares of TDACU stock opened at $10.27 on Thursday. The company has a fifty day moving average of $10.19. Translational Development Acquisition Corp. has a one year low of $10.00 and a one year high of $10.30.
About Translational Development Acquisition
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
See Also
- Five stocks we like better than Translational Development Acquisition
- What is the Hang Seng index?
- Analysts Say Unilever Has the Leverage to Hit New Highs
- How to Invest in Small Cap Stocks
- Homebuilders: Oversold, Undervalued, and Ready to Run?
- 3 Healthcare Dividend Stocks to Buy
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.